Stock NILE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Nile Therapeutics, Inc. Other OTC

Equities

US6541451018

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Nile Therapeutics, Inc.
Apr. 24 Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug MT
Apr. 24 Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy CI

Chart calendar Nile Therapeutics, Inc.

65688231e92.yv8kbxlpBZkge_2OuLJANpr1dQchueXHbP61QvSgd7g.h4heAXIiT_hmDojfztp3TN-cJmNlw6aFIL_4HZfuItyZu3IMbll0_kQNyQ~28df8bd43e9f2b97ae7ef7226c965139

Upcoming events on Nile Therapeutics, Inc.

Today 08:30 am CAP-1002 DMD Update Call
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-05 Q4 2024 Earnings Release (Projected)

Past events on Nile Therapeutics, Inc.

2024-04-03 01:30 pm Cantor Fitzgerald Muscular Dystrophy Symposium
2024-03-26 02:00 pm H.C. Wainwright Cell Therapy Virtual Conference
2024-03-06 11:45 am MDA Clinical and Scientific Conference
2024-02-29 04:30 pm Q4 2023 Earnings Call
2024-02-29 04:05 pm Q4 2023 Earnings Release
2023-11-14 04:30 pm Q3 2023 Earnings Call
2023-11-14 04:05 pm Q3 2023 Earnings Release
2023-10-25 01:00 pm Business Update Call
2023-10-10 Cell & Gene Meeting on the Mesa Conference
2023-10-06 03:30 pm World Muscle Society International Congress
2023-09-29 08:30 am Business Update Call
2023-08-07 04:30 pm Q2 2023 Earnings Call
2023-08-07 04:05 pm Q2 2023 Earnings Release
2023-06-30 11:45 am Parent Project Muscular Dystrophy Conference
2023-06-21 04:00 pm Maxim Group Virtual Healthcare Conference
2023-06-12 01:00 pm Annual Gieneral Meeting
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:01 pm Q1 2023 Earnings Release
2023-03-18 Muscular Dystrophy Association Clinical & Scientific Conference
2023-03-15 04:30 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		1,01
0,84
19.43%		0,31
0,25
23.12%		0,24
0,22
10.07%		2,55
1,60
59.87%		25,2
21,0
19.64%
21,4

EBITDA
Million USD		Released
Forecast
Spread 		-7,73
-8,40
7.93%		0,00
0,00
- 		-20,9
-19,4
-7.93%		-29,2
-30,1
3.11%		-22,8
-30,4
25.03%
-29,8

EBIT
Million USD		Released
Forecast
Spread 		-7,73
-8,26
6.39%		-13,7
-13,5
-1.26%		-20,9
-19,2
-9.1%		-29,7
-30,2
1.56%		-23,9
-28,1
15.08%
-34,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,64
-8,17
6.5%		-13,7
-13,5
-1.25%		-20,0
-18,3
-9.24%		-29,0
-29,8
2.49%		-22,3
-26,6
16.21%
-33,4

Net income
Million USD		Released
Forecast
Spread 		-7,64
-8,17
6.5%		-13,7
-13,5
-1.25%		-20,0
-18,3
-9.24%		-29,0
-29,8
2.49%		-22,3
-26,6
16.2%
-33,4

EPS
USD		Released
Forecast
Spread 		-2,06
-1,97
-4.83%		-0,88
-0,88
0%		-0,87
-0,80
-8.75%		-1,18
-1,22
3.01%		-0,83
-1,04
20.19%
-0,97

Announcement Date18/03/2011/03/2110/03/2215/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,24
0,43
-45.22%		0,00
0,00
-


0,00
0,20
- 		1,59
0,14
1036.84%		0,96
0,01
19098%		2,99
0,50
497.34%		3,92
1,60
144.84%		6,19
3,17
95.44%		12,1
7,95
52.05%
9,70


4,41


4,72


9,70

EBITDA
Million USD		Released
Forecast
Spread


-6,38
-4,80
-32.91%


-7,32
-6,00
-22.03%		-6,48
-7,00
7.46%		-7,87
-8,50
7.36%		-7,95
-8,00
0.57%		-7,49
-8,60
12.88%


-0,76
-7,60
90.06%
-3,60


-10,3


-10,0


-5,80

EBIT
Million USD		Released
Forecast
Spread


-6,38
-4,43
-44.14%


-7,32
-7,07
-3.55%		-6,48
-7,85
17.49%		-8,07
-8,57
5.9%		-8,18
-9,27
11.7%		-7,75
-8,98
13.71%		-6,86
-9,33
26.41%		-1,06
4,31
-124.68%
-3,81


-8,89


-9,63


-4,73

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-6,19
-4,46
-38.71%


-7,11
-7,07
-0.54%		-6,37
-7,47
14.67%		-7,72
-8,49
9.06%		-7,77
-8,39
7.46%		-7,37
-8,73
15.62%		-6,39
-9,15
30.12%		-0,76
-5,06
84.94%
-3,48


-8,94


-9,45


-4,78

Net income
Million USD		Released
Forecast
Spread


-6,19
-4,46
-38.71%


-7,11
-7,07
-0.54%		-6,37
-7,47
14.67%		-7,72
-8,49
9.06%		-7,77
-8,39
7.46%		-7,37
-8,73
15.62%		-6,39
-9,15
30.12%		-0,76
-5,06
84.94%
-3,48


-8,94


-9,45


-4,78

EPS
USD		Released
Forecast
Spread


-0,26
-0,19
-36.84%		-0,32


-0,29
-0,26
-13.73%		-0,26
-0,31
15.22%		-0,31
-0,34
8.82%		-0,31
-0,32
3.13%		-0,29
-0,35
16.35%		-0,25
-0,30
17.58%		-0,02
-0,20
89.74%
-0,11


-0,29


-0,30


-0,13

Announcement Date06/08/2010/03/2210/05/2210/08/2210/11/2215/03/2311/05/2307/08/2314/11/2329/02/24----

Upcoming sector events for Nile Therapeutics, Inc.

2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 07:00 am NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
More events

Past sector events for Nile Therapeutics, Inc.

Today HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CAPR Stock
  4. Stock
  5. Calendar Nile Therapeutics, Inc.